Category stocks

Abbvie Inc. Q2 2026 Earnings Call Summary

Strategic Performance and Market Dynamics - Performance beat was driven by double-digit growth in SKYRIZI, RINVOQ, and the neuroscience portfolio, all exceeding 20% growth. - Management attributes SKYRIZI's psoriasis leadership to a distinct profile of durable skin clearance and...</stron